Molecular structure of Tazobactam sodium, CAS Number: 89785-84-2
Tazobactam sodium (CAS 89785-84-2)
See product citations (2)
Alternate Names:
YTR-830
Application:
Tazobactam sodium is a β-lactamase inhibitor and antibacterial agent
CAS Number:
89785-84-2
Purity:
≥97%
Molecular Weight:
322.28
Molecular Formula:
C10H11N4NaO5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Tazobactam sodium is a LACTB (beta-lactamase) inhibitor. As well as an inhibitor of cell wall synthesis. Tazobactam sodium, a compound widely employed in scientific research, has found utility in various applications. It has been utilized to investigate the mechanism of action of beta-lactamase inhibitors and explore the biochemical and physiological impacts of antibiotics. Moreover, Tazobactam sodium has been used in studying the effects of antibiotics on bacterial resistance.
Tazobactam sodium (CAS 89785-84-2) References
- [Determination of target compounds in cefoperazone sodium and tazobactam sodium for injection by capillary electrophoresis]. | Jiang, R. and Sun, G. 2012. Se Pu. 30: 103-6. PMID: 22667102
- Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children. | Downes, KJ., et al. 2017. JAMA Pediatr. 171: e173219. PMID: 28973124
- The effects of antibiotic type and extender storage method on sperm quality and antibacterial effectiveness in fresh and cooled-stored stallion semen. | Hernández-Avilés, C., et al. 2018. Theriogenology. 122: 23-29. PMID: 30219312
- Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium-Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects. | Chen, N., et al. 2020. Front Pharmacol. 11: 1033. PMID: 32733255
- Imipenem-resistant Pseudomonas aeruginosa treated with piperacillin/tazobactam in a patient with severe pneumonia: a case report and related literature review. | He, L., et al. 2021. Ann Palliat Med. 10: 810-817. PMID: 33545803
- Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients. | Wang, XX., et al. 2021. World J Clin Cases. 9: 8694-8701. PMID: 34734047
- Bloodstream infection and pneumonia caused by Chlamydia abortus infection in China: a case report. | Zhu, C., et al. 2022. BMC Infect Dis. 22: 181. PMID: 35197012
- Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. | Bryson, HM. and Brogden, RN. 1994. Drugs. 47: 506-35. PMID: 7514977
- Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration. | Chung, KC., et al. 1995. Am J Health Syst Pharm. 52: 1554-6. PMID: 7552901
- Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags. | Moon, YS., et al. 1995. Am J Health Syst Pharm. 52: 999-1001. PMID: 7641040
- Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration. | Choi, JS., et al. 1994. Am J Hosp Pharm. 51: 2273-6. PMID: 7801988
- Stability of piperacillin sodium in the presence of tazobactam sodium in 5% dextrose and normal saline injections. | Mathew, M., et al. 1994. J Clin Pharm Ther. 19: 397-9. PMID: 7876373
- Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions. | Park, TW., et al. 1995. Am J Health Syst Pharm. 52: 2022-4. PMID: 8528873
Inhibitor of:
LACTB.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Tazobactam sodium, 100 mg | sc-205853 | 100 mg | $116.00 | |||
Tazobactam sodium, 500 mg | sc-205853A | 500 mg | $354.00 |